Skip to main content
Springer Nature Link
Log in

Military Standards for Anaphylaxis: Aligning Allergy Science, Operational Risk, and Waiver Documentation

  • Review
  • Published:
Save article
View saved research
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of the Review

Allergic disease is common in the United States, and a growing number of otherwise qualified applicants and service members present with histories of food allergy, venom allergy, medication reactions, physical urticarias, or prior anaphylaxis. The challenge for clinicians is to translate a nuanced allergy-immunology evaluation into strict military accession and retention standards designed for readiness, austere care, and deployability, rather than for diagnosis alone.

Recent Findings

The current accession standard disqualifies a history of anaphylaxis other than to a single medication or medication class; systemic allergic reactions to biting or stinging insects unless limited to a large local reaction or accompanied by documentation of 3 years of maintenance venom immunotherapy; acute allergic reactions to fish, crustaceans, shellfish, peanuts, or tree nuts when food-specific IgE is accompanied by a correlating clinical history; and cold- or exercise-induced urticaria [1]. Retention standards are more functional and focus on recurrent anaphylaxis that persists despite treatment, requires long-term duty limitations, or prevents return to duty [2]. Newer therapeutic options, including oral immunotherapy (OIT) and omalizumab, raise reaction thresholds for selected patients but do not establish unrestricted tolerance.[3, 4] This latter point precludes serving in operational settings.

Summary

A clinically useful waiver evaluation should differentiate sensitization from clinical allergy. Resolved allergy versus desensitization or sustained unresponsiveness should also be determined. The identification of cofactors that lower reaction thresholds, and specifying whether the individual can safely train, deploy, subsist on field rations, and function without refrigeration-dependent or injectable therapy is imperative. Major gaps remain. These include few military-specific outcome data on allergy waivers, limited validated biomarkers that predict future anaphylaxis severity, and no standardized pathway for cold- or exercise-induced urticaria comparable with the venom immunotherapy exception.

Clinical Take-Home Points

Military allergy standards are risk standards, not allergy practice parameters. The operative question is whether the condition predicts unacceptable operational risk or duty limitation.

IgE sensitization without a convincing clinical history should not be equated with food (or venom) allergy; conversely, a remote history of anaphylaxis requires objective documentation of resolution or durable risk reduction.

A successful oral food challenge is the most useful way to document tolerance, but it must specify food form, dose schedule, cumulative amount, observation findings, and pass/fail outcome.

Venom allergy is unique because DoDI explicitly recognizes a waiver-supporting pathway after 3 years of maintenance venom immunotherapy.

Oral immunotherapy (OIT), sublingual immunotherapy (SLIT), and omalizumab may reduce risk, but ongoing dependence on daily dosing, injections, or refrigeration may conflict with accession standards and deployment requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

Data Availability

No datasets were generated or analysed during the current study.

References

  1. Department of Defense. Instruction 6130.03, Volume 1: Military Medical Standards: Appointment, Enlistment, or Induction. Department of Defense. 2018.

  2. Department of Defense. Instruction 6130.03, Volume 2: Medical Standards for Military Service: Retention. Department of Defense. 2020.

  3. Iglesia EGA, Kwan M, Virkud YV, Iweala OI. Management of Food Allergies and Food-Related Anaphylaxis. JAMA. 2024;331(6):510–21. https://doi.org/10.1001/jama.2023.26857.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, et al. Omalizumab for the Treatment of Multiple Food Allergies. N Engl J Med. 2024;390(10):889–99. https://doi.org/10.1056/NEJMoa2312382.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bottoms-McClain L, Giri A, Ng AE. Diagnosed Allergic Conditions in Adults: United States, 2024. NCHS Data Brief. 2026;545. https://doi.org/10.15620/cdc/174634

  6. Golden DB, Demain J, Freeman T, Graft D, Tankersley M, Tracy J, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28–54. https://doi.org/10.1016/j.anai.2016.10.031.

    Article  PubMed  Google Scholar 

  7. Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45. https://doi.org/10.1111/all.12437.

    Article  CAS  PubMed  Google Scholar 

  8. Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, Anaphylaxis, et al. A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124–76. https://doi.org/10.1016/j.anai.2023.09.015.

    Article  PubMed  Google Scholar 

  9. Niggemann B, Beyer K. Factors augmenting allergic reactions. Allergy. 2014;69(12):1582–7. https://doi.org/10.1111/all.12532.

    Article  CAS  PubMed  Google Scholar 

  10. Wolbing F, Fischer J, Koberle M, Kaesler S, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy. 2013;68(9):1085–92. https://doi.org/10.1111/all.12193.

    Article  CAS  PubMed  Google Scholar 

  11. Munoz-Cano R, Pascal M, Araujo G, Goikoetxea MJ, Valero AL, Picado C, et al. Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis. Front Immunol. 2017;8:1193. https://doi.org/10.3389/fimmu.2017.01193.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Worm M, Scherer K, Kohli-Wiesner A, Rueff F, Mahler V, Lange L, et al. Food-induced anaphylaxis and cofactors - data from the anaphylaxis registry. Allergol Select. 2017;1(1):21–7. https://doi.org/10.5414/ALX01401E.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zogaj D, Ibranji A, Hoxha M. Exercise-induced Anaphylaxis: the Role of Cofactors. Mater Sociomed. 2014;26(6):401–4. https://doi.org/10.5455/msm.2014.26.401-404.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Barg W, Wolanczyk-Medrala A, Obojski A, Wytrychowski K, Panaszek B, Medrala W. Food-dependent exercise-induced anaphylaxis: possible impact of increased basophil histamine releasability in hyperosmolar conditions. J Investig Allergol Clin Immunol. 2008;18(4):312–5.

    CAS  PubMed  Google Scholar 

  15. Shin M. Food allergies and food-induced anaphylaxis: role of cofactors. Clin Exp Pediatr. 2021;64(8):393–9. https://doi.org/10.3345/cep.2020.01088.

    Article  CAS  PubMed  Google Scholar 

  16. Hompes S, Kohli A, Nemat K, Scherer K, Lange L, Rueff F, et al. Provoking allergens and treatment of anaphylaxis in children and adolescents–data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol. 2011;22(6):568–74. https://doi.org/10.1111/j.1399-3038.2011.01154.x.

    Article  PubMed  Google Scholar 

  17. Dua S, Ruiz-Garcia M, Bond S, Durham SR, Kimber I, Mills C, et al. Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study. J Allergy Clin Immunol. 2019;144(6):1584–e942. https://doi.org/10.1016/j.jaci.2019.06.038.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Matsuo H, Morimoto K, Akaki T, Kaneko S, Kusatake K, Kuroda T, et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy. 2005;35(4):461–6. https://doi.org/10.1111/j.1365-2222.2005.02213.x.

    Article  CAS  PubMed  Google Scholar 

  19. Pascal M, Munoz-Cano R, Mila J, Sanz ML, Diaz-Perales A, Sanchez-Lopez J, et al. Nonsteroidal anti-inflammatory drugs enhance IgE-mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti-inflammatory drugs. Clin Exp Allergy. 2016;46(8):1111–9. https://doi.org/10.1111/cea.12735.

    Article  CAS  PubMed  Google Scholar 

  20. Fernandes RA, Regateiro F, Pereira C, Faria E, Pita J, Todo-Bom A, et al. Anaphylaxis in a food allergy outpatient department: one-year review. Eur Ann Allergy Clin Immunol. 2018;50(2):81–8. https://doi.org/10.23822/EurAnnACI.1764-1489.45.

    Article  CAS  PubMed  Google Scholar 

  21. Dubois AEJ, Turner PJ, Hourihane J, Ballmer-Weber B, Beyer K, Chan CH, et al. How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods? Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop. Allergy. 2018;73(7):1383–92. https://doi.org/10.1111/all.13405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Zhu J, Pouillot R, Kwegyir-Afful EK, Luccioli S, Gendel SM. A retrospective analysis of allergic reaction severities and minimal eliciting doses for peanut, milk, egg, and soy oral food challenges. Food Chem Toxicol. 2015;80:92–100. https://doi.org/10.1016/j.fct.2015.02.023.

    Article  CAS  PubMed  Google Scholar 

  23. Wasserman RL, Editorial. Prediction of severity of food allergy. Front Allergy. 2025;6:1717271. https://doi.org/10.3389/falgy.2025.1717271.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Grimshaw KE, King RM, Nordlee JA, Hefle SL, Warner JO, Hourihane JO. Presentation of allergen in different food preparations affects the nature of the allergic reaction–a case series. Clin Exp Allergy. 2003;33(11):1581–5. https://doi.org/10.1046/j.1365-2222.2003.01795.x.

    Article  CAS  PubMed  Google Scholar 

  25. Panel NI-SE, Boyce JA, Assa’ad A, Burks AW, Jones SM, Sampson HA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):S1–58. https://doi.org/10.1016/j.jaci.2010.10.007.

    Article  Google Scholar 

  26. Sicherer SH. Food allergy. Lancet. 2002;360(9334):701–10. https://doi.org/10.1016/S0140-6736(02)09831-8.

    Article  PubMed  Google Scholar 

  27. Biswas R, Fried JM, Curotto de Lafaille MA. Expanding the Immunologic and Neuronal Landscape of IgE-Mediated Anaphylaxis. Immunol Rev. 2026;337(1):e70078. https://doi.org/10.1111/imr.70078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. BioRender. https://BioRender.com/zdfk7iv Accessed.

  29. Bird JA, Leonard S, Groetch M, Assa’ad A, Cianferoni A, Clark A, et al. Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report. J Allergy Clin Immunol Pract. 2020;8(1):75–e9017. https://doi.org/10.1016/j.jaip.2019.09.029.

    Article  PubMed  Google Scholar 

  30. Food US. and Drug Administration: FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure. (2024). https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-help-reduce-allergic-reactions-multiple-foods-after∂ß. Accessed.

Download references

Funding

The authors received no financial support for the authorship and/or publication of this article.

Author information

Authors and Affiliations

  1. Rutgers New Jersey Medical School, Newark, NJ, USA

    Kyleigh E. Brimmer

  2. Allergy & Immunology Service, Department of Medicine, Alexander T. Augusta Military Medical Center, Fort Belvoir, VA, USA

    Sarah Spriet

  3. Division of Allergy and Immunology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Maureen M. Petersen

Authors
  1. Kyleigh E. Brimmer
    View author publications

    Search author on:PubMed Google Scholar

  2. Sarah Spriet
    View author publications

    Search author on:PubMed Google Scholar

  3. Maureen M. Petersen
    View author publications

    Search author on:PubMed Google Scholar

Contributions

K.E.B and M.M.P wrote the main manuscript text. S.S prepared figure 1. All authors reviewed the manuscript.

Corresponding author

Correspondence to Maureen M. Petersen.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brimmer, K.E., Spriet, S. & Petersen, M.M. Military Standards for Anaphylaxis: Aligning Allergy Science, Operational Risk, and Waiver Documentation. Curr Allergy Asthma Rep 26, 49 (2026). https://doi.org/10.1007/s11882-026-01291-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1007/s11882-026-01291-4

Keywords